BlackRock Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BFA
BIT
BlackRock Advisors's HAE Position: Q4 2016 in Review
BlackRock Advisors increased its Haemonetics (HAE) stake by 2.9% in Q4 2016, buying an estimated $29.3K and bringing the position to 27,612 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.
BlackRock Advisors first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2013. 197 funds tracked by Wall St. Rank hold HAE as of Q4 2016.
- BlackRock Advisors held 27,612 shares of Haemonetics worth $1.11M as of Q4 2016.
- BlackRock Advisors bought 776 Haemonetics shares in Q4 2016, an estimated $29.3K.
- Haemonetics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1807 holding.
- BlackRock Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Haemonetics position peaked at $10.1M in Q2 2013.
- 197 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.